176 related articles for article (PubMed ID: 16707468)
1. KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand.
Smakman N; van den Wollenberg DJ; Elias SG; Sasazuki T; Shirasawa S; Hoeben RC; Borel Rinkes IH; Kranenburg O
Cancer Res; 2006 May; 66(10):5403-8. PubMed ID: 16707468
[TBL] [Abstract][Full Text] [Related]
2. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
[TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
4. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5.
Liu XY; Qiu SB; Zou WG; Pei ZF; Gu JF; Luo CX; Ruan HM; Chen Y; Qi YP; Qian C
Mol Ther; 2005 Apr; 11(4):531-41. PubMed ID: 15771956
[TBL] [Abstract][Full Text] [Related]
5. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin.
Ammirante M; Di Giacomo R; De Martino L; Rosati A; Festa M; Gentilella A; Pascale MC; Belisario MA; Leone A; Turco MC; De Feo V
Cancer Res; 2006 Apr; 66(8):4385-93. PubMed ID: 16618764
[TBL] [Abstract][Full Text] [Related]
6. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
[TBL] [Abstract][Full Text] [Related]
7. [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells].
Tong HX; Zhang JH; Ma L; Lu CW; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):327-30. PubMed ID: 16923369
[TBL] [Abstract][Full Text] [Related]
8. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors.
Schimmer AD; Thomas MP; Hurren R; Gronda M; Pellecchia M; Pond GR; Konopleva M; Gurfinkel D; Mawji IA; Brown E; Reed JC
Cancer Res; 2006 Feb; 66(4):2367-75. PubMed ID: 16489043
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Kuroda T; Rabkin SD; Martuza RL
Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha induces p53 up-regulated modulator of apoptosis expression in colorectal cancer cell lines.
Pastor DM; Irby RB; Poritz LS
Dis Colon Rectum; 2010 Mar; 53(3):257-63. PubMed ID: 20173470
[TBL] [Abstract][Full Text] [Related]
11. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA
Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
13. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
[TBL] [Abstract][Full Text] [Related]
14. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
[TBL] [Abstract][Full Text] [Related]
15. 17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines.
Vasilevskaya IA; O'Dwyer PJ
Biochem Pharmacol; 2005 Aug; 70(4):580-9. PubMed ID: 15993848
[TBL] [Abstract][Full Text] [Related]
16. [Induction of apoptosis in various cancer cell lines by human soluble TRAIL expressed in Escherichia coli].
Zheng X; Guan X; Lin Z
Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):190-2. PubMed ID: 11798756
[TBL] [Abstract][Full Text] [Related]
17. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Toyota H; Kondo S; Kyo S; Mizuguchi J
Anticancer Res; 2006; 26(1A):99-105. PubMed ID: 16475685
[TBL] [Abstract][Full Text] [Related]
18. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
Secchiero P; Candido R; Corallini F; Zacchigna S; Toffoli B; Rimondi E; Fabris B; Giacca M; Zauli G
Circulation; 2006 Oct; 114(14):1522-30. PubMed ID: 17000905
[TBL] [Abstract][Full Text] [Related]
19. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
[TBL] [Abstract][Full Text] [Related]
20. Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis.
Tomasetti M; Andera L; Alleva R; Borghi B; Neuzil J; Procopio A
FEBS Lett; 2006 Apr; 580(8):1925-31. PubMed ID: 16529749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]